Login / Signup

Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.

Frederic ArnoldLukas WestermannSiegbert RiegElke Neumann-HaefelinPaul Marc BieverGerd WalzJohannes KalbhennYakup Tanriver
Published in: BMC nephrology (2020)
UFH fails to prevent early clotting events in the dialysis circuit during COVID-19. For patients, who do not require effective systemic anticoagulation, regional citrate dialysis is the most effective strategy. For patients, who require effective systemic anticoagulation, the usage of LMWH results in the longest circuit life spans. The proposed anticoagulatory strategies are safe, can easily be monitored, and allow an individualized treatment.
Keyphrases
  • atrial fibrillation
  • venous thromboembolism
  • chronic kidney disease
  • end stage renal disease
  • acute kidney injury
  • smoking cessation